Partnership

We believe that models trained on our human datasets can help with nearly every problem in cancer drug development, from predicting human responses to investigational cancer drugs, to target identification in preclinical research.

Interested in learning more about our work? Check out our Application page and case studies, and reach out to partnerships@noetik.ai to discuss working together.

Current collaborators

GSK Licenses Noetik’s AI Foundation Models in Anchor Partnership to Transform Cancer Therapeutic Research and Development

Read More

Agenus and Noetik Enter Collaboration to Develop AI-Enabled Predictive Biomarkers

Read More

Proud member of the NVIDIA Inception and AWS Gen AI accelerator.